Clinical Trials Ontario Information Session

Waterloo, ON
Wednesday, Feb 5, 2020 at 2:30 PM EST 
{ "name":"Clinical Trials Ontario Information Session", "description": "https://ticketfi.com/event/3714/clinical-trials-ontario-information-session\n\n\"The Centre for Bioengineering and Biotechnology and the University of Waterloo Office of Research Ethics are pleased to host an information session with Clinical Trials Ontario.\\nClinical Trials Ontario (CTO) representatives will detail:\\n\\n\\n\\t The CTO model including how it works and how it focuses on all research, not just clinical trials.\\n\\tThe new QuickSTART program\\n\\tChallenges around REB parity and the CTO Qualification Program\\n\\tChallenges of contracts, standardizing documents, training of researcher teams, online systems, etc.\\n\\tThe Trial Site Network\\n\\nThe CTO Trial Site Network is a growing network of contacts at over 85 academic hospitals, community hospitals, and researcher networks across Ontario, who are ready to receive new industry-sponsored trials and pilot studies that align with their core areas of interest. This new network provides a one-stop-shop for companies looking to conduct clinical trials, observational studies or technology pilots in Ontario's Healthcare system. At no cost, they can work with CTO's Industry Concierge to share their opportunity with the participants in the Trial Site Network. The Industry Concierge will then assess whether any of the sites are interested in the study and facilitate introductions to any sites who are.  Think of it as a clinical research \\/ innovation broker. It is CTO's intent to help provide new connections with industry sponsors in their continued quest in attracting additional industry sponsors and trials to Canada. CTO is working with CROs and global pharma including IQVIA, Roche, and Medpace who would like to use the network to source new trial sites in Ontario and to support landscaping requests for future trials.\\n\\nSpeakers:\\n\\nAndrew Haller, PhD, Industry Outreach Associate, Clinical Trials Ontario\\nMatthew D’Ascanio, Associate Director – Streamlined Research Ethics Review, Clinical Trials Ontario\\nLOCATION: EC5 1111 Enterprise theatre\\n\"", "startDate":"2020-02-05", "endDate":"2020-02-05", "startTime":"14:30", "endTime":"15:30", "location":"University of Waterloo East Campus 5 - 305 Phillip St Waterloo ON N2L 5Z5 Canada", "label":"Add to Calendar", "options":[ "Apple", "Google", "iCal", "Microsoft365", "Outlook.com", "Yahoo" ], "timeZone":"US/Eastern", "trigger":"click", "inline":true, "listStyle":"modal", "iCalFileName":"invite.ics" }

Event Details

The Centre for Bioengineering and Biotechnology and the University of Waterloo Office of Research Ethics are pleased to host an information session with Clinical Trials Ontario.
Clinical Trials Ontario (CTO) representatives will detail:

  •  The CTO model including how it works and how it focuses on all research, not just clinical trials.
  • The new QuickSTART program
  • Challenges around REB parity and the CTO Qualification Program
  • Challenges of contracts, standardizing documents, training of researcher teams, online systems, etc.
  • The Trial Site Network
The CTO Trial Site Network is a growing network of contacts at over 85 academic hospitals, community hospitals, and researcher networks across Ontario, who are ready to receive new industry-sponsored trials and pilot studies that align with their core areas of interest. This new network provides a one-stop-shop for companies looking to conduct clinical trials, observational studies or technology pilots in Ontario's Healthcare system. At no cost, they can work with CTO's Industry Concierge to share their opportunity with the participants in the Trial Site Network. The Industry Concierge will then assess whether any of the sites are interested in the study and facilitate introductions to any sites who are.  Think of it as a clinical research / innovation broker. It is CTO's intent to help provide new connections with industry sponsors in their continued quest in attracting additional industry sponsors and trials to Canada. CTO is working with CROs and global pharma including IQVIA, Roche, and Medpace who would like to use the network to source new trial sites in Ontario and to support landscaping requests for future trials.

Speakers:

Andrew Haller, PhD, Industry Outreach Associate, Clinical Trials Ontario
Matthew D’Ascanio, Associate Director – Streamlined Research Ethics Review, Clinical Trials Ontario
LOCATION: EC5 1111 Enterprise theatre

Speakers

Matthew D'Ascanio
Clinical Trials Ontario
Associate Director – Streamlined Research Ethics Review
Andrew Haller, PhD
Clinical Trials Ontario
Industry Outreach Associate

Location

University of Waterloo East Campus 5
305 Phillip Street - University of Waterloo East Campus 5 Waterloo, ON N2L 5Z5 CA

Tickets

Type
Price
Registration
Free

Organizer Details

Logo - Centre for Bioengineering and Biotechnology, University of Water

Centre for Bioengineering and Biotechnology, University of Water

CBB is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.

More than 155 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.

Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.

Top research applications:

  • Computational and Disease Modelling
  • Imaging
  • Machine Learning and Artificial Intelligence
  • Medical Devices
  • Sensors and Diagnostics
  • Therapeutics
  • Biomarkers
  • Biomaterials